Alpha9 Theranostics
Alpha9 Theranostics raised US$126.5M in Series C funding.
Email and contact information
Company website: www.alpha9tx.com
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: , (Canada)
Industry: Healthcare, Biotechnology
Business model:
Funding
- Total funding amount: $126,526,177 (in USD)
- Estimated valuation: $632,630,885.00
- Latest deal type: Series C
- First fundind year: 2024
Growth
Founders:
Top investors:
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK